When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the ...

The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...

Many Indian firms chase quick returns, rely on imported technology, and underinvest in research. But innovation needs ...

The capped upside and unlimited downside risk make MRNY unattractive unless Moderna's share price stabilizes and recovers ...

The new results helped boost Moderna’s stock by more than 4% in early trading June 30, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA.

Karnataka Health Minister Dinesh Gundu Rao released a report confirming no direct link between COVID-19 vaccines and sudden ...

The author says the action creates mistrust of the committee’s vaccine recommendations and further increases patients’ and ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

For decades, one of the world’s most contagious diseases was considered eradicated in the U.S. But today, measles is roaring ...

We may or may not be out of the woods, but focusing on the short-term performance of stocks is not the best strategy.

The company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine. Moderna (NASDAQ: ...

Vaccines have been rigorously tested, reviewed, and monitored for decades. They are one of the greatest success stories in ...